Investor Presentaiton

EML Payments H1 FY2022 Financial Results Key Financial Messages - - - - GDV growth strong - up 209% driven by Sentenial acquisition and growth in all segments; Revenue growth strong - up 20% on PCP with growth from all segments; Gross Profit of $75.4m', up 12% on PCP, with GP margin of 66% down on PCP by 5%. GP impacted in H1 by a drop of $2.7m in net interest income relative to PCP, or a 4% impact on GP margin; Underlying Overheads growth of $9.3m², up 24% on PCP impacted by additional resources to support the CBI remediation, insurance and audit cost increases and the consolidation of Sentenial for 3 months from October 2021; - The surge in Omicron in late November led to social distancing restrictions being introduced in December in certain key markets for our G&l segment, particularly Canada, Germany and the UK. We saw volumes in these markets impacted in the key seasonal period, impacting G&l volumes in H1. Despite this, G&I recorded record H1 GDV at $0.9bn; Expect 2H improvement - A number of initiatives have been completed or are underway that will deliver benefits to H2 FY2022 performance; We remain in line with our guidance expectations as H2 FY2022 will benefit from improved trading conditions, including: - improved interest revenue with further investments in bonds and the benefit of 40bps improvement in the GBP cash rate (+15bps in Dec 21 and +25bps Feb 22); - improved economics on revised commercial agreements with our schemes; introduction of new inactive account maintenance fees on European GPR programs is expected to result in a recurring revenue stream and a non- recurring catch up for historical programs; commenced launching new European programs in December as CBI licence restrictions eased: - Provided $10.5m for highly likely future legal costs in relation to the Group proceedings brought by Shine Lawyers, which we intend to vigorously defend. We will be seeking a Court order for security over these costs. We have an insurance policy which we expect to cover this event, subject to a deductible element, however this asset cannot be recognised until it is considered virtually certain. 1 Gross Profit is stated excluding the non-cash amortisation of the AASB3 fair value uplift to bond investments. 2 Underlying Overheads excludes CBI and related costs including the provision for the Shine Group Proceedings litigation defence 23

View entire presentation